Diabetes Drug Developments At Sanofi-Aventis, Merck
Diabetes Drug Developments At Sanofi-Aventis, Merck
Sanofi’s study of diabetes patients using Lantus in combination with Apidra showed improved patient outcomes.
Read more on Forbes
Tags: Developments, Diabetes, Drug, Merck, SanofiAventis